Skip to content

Clinical study of additive manufacturing custom long bone prosthesis

Clinical study of additive manufacturing custom long bone prosthesis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400095034
Enrollment
Unknown
Registered
2024-12-31
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

It is applicable to long bone diseases such as bone tumors, traumatic bone defects, nonunion of fractures, and severe bone infections.

Interventions

Single-arm study:Implant long bone prostheses into subjects who meet the enrollment criteria.

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Subjects with long bone shaft defects greater than 4cm due to bone tumors, traumatic bone defects, severe bone infection post-resection (with infection well-controlled), congenital or acquired long bone pseudoarthrosis, or non-union of long bone fractures, requiring stability reconstruction; 2.Individuals who have not participated in any other clinical trials within the past 3 months; 3.Those who fully understand the benefits and risks of customized medical devices, are still willing to participate, and have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Any subject unwilling to comply with postoperative instructions or medical advice; 2.Any subject with insufficient soft tissue coverage at the surgical site; 3.Subjects with congenital or acquired increased bone fragility, or those with severe calcification disorders; 4.Subjects with infections involving the surgical site or with local inflammatory manifestations that are not effectively controlled; 5.Psychiatric diseases; 6.Morbid obesity (Body Mass Index [BMI] = 40); 7.Pregnancy; 8.Aggressive arthritis, osteomalacia, osteolysis, and severe osteoporosis (T-score < -3.5). Osteolysis and osteoporosis are relative contraindications and may potentially affect the outcome of surgical treatment; 9.Subjects suspected or proven to be allergic or intolerant to metallic materials; 10.Any disease that may hinder the surgical benefits of the implant; 11.Any other subjects deemed unsuitable by the investigator.

Design outcomes

Primary

MeasureTime frame
The stability of the prosthesis;

Secondary

MeasureTime frame
The score of Musculoskeletal Tumor Society (MSTS);

Countries

China

Contacts

Public ContactSun Wei

Shanghai General Hospital

viv-sun@163.com+86 21 36123526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026